Walgreens Boots Alliance shareholders gave the thumbs up to the private-equity buyout by Sycamore Partners, with about 96% of ...

WBA Stock Price Performance Walgreens shares have struggled in the past year, plummeting 62.9% compared with the industry’s 47.2% decline and the S&P 500’s 25.9% growth.

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens Boots Alliance Inc. (NASDAQ: WBA) is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% ...

Walgreens Boots Alliance has significantly underperformed other retail stocks over the past year and analysts remain cautious about the stock’s prospects.

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Operating loss was $325 million compared to $436 million in the prior-year period reflecting improved performance at VillageMD and Shields, Walgreens said in the first-quarter financial report.

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens Boots Alliance, the parent company of British retailer Boots, has seen its stock decline during a turbulent week after facing backlash over its allegedly "woke" Christmas advert.

In March, the two agreed to a $10 billion deal that will see Sycamore take Walgreens private, ending nearly a century of public trading. The transaction is anticipated to close in the third or fourth ...